EASL Secretary General Aleksander Krag offers his vision for the EASL Congress 2024, after which Hannes Hagstrom shared some impressions.
EASL Secretary General Aleksander Krag and our other guests, Hannes Hagstrom and Michelle Long, join Jörn Schattenberg and Roger Green to discuss MASLD-related highlights of EASL Congress 2024.
This week’s vault episode offers the last time Stephen Harrison presented results of a specific drug trial on the podcast.
This second conversation with Dimitar Tonev and Roger Green focus on some of the elements of Stephen’s personality that made him a role model for the entire community in Dimitar’s eyes.
Dimitar Tonev and Roger Green discuss Stephen Harrison’s role as a major innovator in the MASLD space, with Dimitar focusing largely on Stephen developing the first clinical trial site network.
Jörn Schattenberg, Donna Cryer and Roger Green continue their conversation of Stephen Harrison by discussing his consistent efforts to be sure the voices of patients and allied health providers were included in key conversations.
Donna Cryer, Jörn Schatenberg and Roger Green reflect on Stephen Harrison’s ability to bring together all the various elements of the MASLD community in pursuit of knowledge and a first approved drug.
In two separate conversations, Global Liver Institute Founder and CEO and industry executive and consultant hepatologist Dimitar Tonev share memories of Stephen Harrison with co-hosts Jörn Schattenberg and Roger Green.
From INCBCN 2023: Last year’s Barcelona context took a “deep dive” into NITs by exploring some early findings from the NAIL-NIT consortium.
This final conversation from #SLDThinkTank 2024 start with the question, “Next year?” Two key foci emerge: broadening the set of groups in the meeting and focusing more broadly on the concept of preventive hepatology.
